Stocks
Health Care
tbph
Theravance Biopharma
NASDAQ: TBPH
+0.08 (+0.58%)
13.89
USD
At close at Mar 12, 20:38 UTC
Income Statement
Revenue
64.38M
Gross Profit
64.38M
Operating Income
-46.95M
Pretax Income
47.24M
Net Income
-56.42M
EBITDA
-35.94M
EBIT
-42.07M
Earnings Per Share
-1.1500000000000001
Balance Sheet
Cash & Cash Equivalents
41.17M
Total Debt
47.34M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
189.94M
Book Value Per Share
3.9
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.